Home Search
"life science" - search results
If you're not happy with the results, please do another search
Life Sciences specialist to join Scottish Enterprise co-investment fund
Medical Marketing International Group is to become a partner to the Scottish Enterprise co-investment fund. MMI is the third partner to sign up to the fund.
Latest Deals: 28 May – 03 June 2003
The AltAssets weekly round up of deals done across the world. This week there were 112 active investors in 41 deals and five exits across ten sectors, compared to 99 active investors in 38 deals and no exits the previous week…
Western Europe & Israel: May 2003
Baring targets $500m for global buy-out fund, Industri Kapital veteran sets up new private equity firm, European privately owned companies continue to lose confidence in the economy…
Schroder Ventures closes $400m life sciences fund
Schroder Ventures Life Sciences (SVLS) has closed its third life sciences private equity fund at $402m. ILSF III has attracted commitments from 18 new investors evenly distributed between the US, UK and continental Europe.
Funds: May 2003
Nordic Capital exceeds target size to raise E1.5bn, Partners Group launches first dedicated secondaries fund, Charterhouse lowers target on latest mega-fund, Tenaska plans $700m energy fund, MMC Capital launches third financial services fund, Charterhouse Group holds first close at over $300m, Altira closes fourth energy technology fund…
North America: May 2003
NVCA seeks to defend University of California in disclosure suit, venture investment in Canada plummets, Walden to cut fund size for second time, US pensions and endowments increase allocations to private equity, Altira closes energy technology fund…
Latest Deals: 21 May – 27 May 2003
The AltAssets weekly round up of deals done across the world. This week there were 99 active investors in 38 deals and no exits across nine sectors, compared to 137 active investors in 46 deals and two exits the previous week…
German Wellington Partners recruits venture partner for life science team
Germany-based venture firm, Wellington Partners, has recruited Dr.Thomas Widmann as a venture partner for its life science team. Widmann will be responsible for supporting the firm's existing portfolio companies as well as playing an active role in selecting new investments.
Endurance Biotech Report: Introduction
The shrinking European biotech market is in the midst of a prolonged slump, plagued by tumbling valuations, increasingly limited venture funds and scarce exit opportunities. The introduction to Ernst & Young's Endurance Biotech Report outlines the current state of the industry and explores the avenues left open to struggling life science companies, if they are to succeed or even survive.
Latest Deals: 7 May – 13 May 2003
The AltAssets weekly round up of deals done across the world. This week there were 110 active investors in 43 deals and five exits across 14 sectors, compared to 110 active investors in 41 deals and two exits the previous week…